First American Bank Abb Vie Inc. Transaction History

First American Bank

$1.39 Trillion
Q3 2024

A detailed history of First American Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, First American Bank holds 117,637 shares of ABBV stock, worth $20.7 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares

117,637

Previous 120,319 2.23%

Holding current value

$20.7 Million

Previous $20.6 Billion 12.57%

% of portfolio

1.67%

Previous 1.54%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $439,418 - $534,603	-2,682 Reduced 2.23%	117,637 $23.2 Billion
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $4.96 Million - $5.8 Million	32,071 Added 36.34%	120,319 $20.6 Billion
Q1 2024 Jul 31, 2024	BUY	$159.82 - $182.1 $1.05 Million - $1.2 Million	6,569 Added 5.74%	120,958 $22 Million
Q4 2023 Jul 31, 2024	BUY	$137.6 - $154.97 $130,720 - $147,221	950 Added 0.84%	114,389 $17.7 Million
Q3 2023 Jul 31, 2024	BUY	$133.59 - $154.65 $11,755 - $13,609	88 Added 0.08%	113,439 $16.9 Million
Q2 2023 Jul 31, 2024	SELL	$132.51 - $164.9 $1.21 Million - $1.51 Million	-9,135 Reduced 7.46%	113,351 $15.3 Million
Q1 2023 Jul 31, 2024	SELL	$144.61 - $166.54 $139,548 - $160,711	-965 Reduced 0.78%	122,486 $19.5 Million
Q4 2022 Jul 31, 2024	BUY	$138.31 - $165.87 $2.13 Million - $2.56 Million	15,421 Added 14.27%	123,451 $20 Million
Q3 2022 Jul 31, 2024	BUY	$134.21 - $153.93 $2.62 Million - $3.01 Million	19,555 Added 22.1%	108,030 $14.5 Million
Q2 2022 Jul 31, 2024	SELL	$137.62 - $174.96 $299,598 - $380,887	-2,177 Reduced 2.4%	88,475 $13.6 Million
Q1 2022 Jul 31, 2024	SELL	$131.98 - $163.75 $3.92 Million - $4.86 Million	-29,667 Reduced 24.66%	90,652 $14.7 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $34,162 - $43,225	318 Added 0.36%	88,248 $11.9 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $26,280 - $29,832	-247 Reduced 0.28%	87,930 $9.49 Million
Q2 2021 Jul 13, 2021	SELL	$105.21 - $117.21 $53,657 - $59,777	-510 Reduced 0.58%	88,177 $9.93 Million
Q1 2021 Apr 08, 2021	BUY	$102.3 - $112.62 $35,805 - $39,417	350 Added 0.4%	88,687 $9.6 Million
Q4 2020 Jan 06, 2021	SELL	$80.49 - $108.67 $124,035 - $167,460	-1,541 Reduced 1.71%	88,337 $9.47 Million
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $76,889 - $90,242	-895 Reduced 0.99%	89,878 $7.87 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $7,410 - $9,916	101 Added 0.11%	90,773 $8.91 Million
Q1 2020 Apr 07, 2020	BUY	$64.5 - $97.79 $54,567 - $82,730	846 Added 0.94%	90,672 $6.91 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $6.48 Million - $8.11 Million	89,826 New	89,826 $7.95 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First American Bank, based on Form 13F filings with the SEC.

News

Stay updated on First American Bank with notifications on news.

Account

First American Bank Abb Vie Inc. Transaction History